Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine's Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes.

MLA

Yin, Xuefen, et al. “Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes.” Pharmaceutics, vol. 16, no. 6, June 2024, p. 737. EBSCOhost, https://doi.org/10.3390/pharmaceutics16060737.

APA

Yin, X., Cicali, B., Rodriguez-Vera, L., Lukacova, V., Cristofoletti, R., & Schmidt, S. (2024). Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes. Pharmaceutics, 16(6), 737. https://doi.org/10.3390/pharmaceutics16060737

Chicago

Yin, Xuefen, Brian Cicali, Leyanis Rodriguez-Vera, Viera Lukacova, Rodrigo Cristofoletti, and Stephan Schmidt. 2024. “Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes.” Pharmaceutics 16 (6): 737. doi:10.3390/pharmaceutics16060737.